SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-031012
Filing Date
2023-05-19
Accepted
2023-05-19 16:29:03
Documents
1
Period of Report
2023-05-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4088
  Complete submission text file 0001209191-23-031012.txt   5463
Mailing Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121
Business Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121 8587318389
aTYR PHARMA INC (Issuer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 2401 4TH AVENUE, SUITE 1050 SEATTLE WA 98121
Business Address
Gross Jane A (Reporting) CIK: 0001684258 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37378 | Film No.: 23940569